European Companies Search Engine
Convertible bonds Hrb25 Jan 2005 German Trade Register Announcements, Germany (20/01/2005)
Overview
Text
Schwarz Pharma AG, Monheim (
Unnamed street ??, 40789 Monheim, Germany
). As a result of the conditional increase in the share capital decided on May 10, 2000, 501,611 new shares with a total nominal value of EUR 652,094.30 were issued in the financial year ended December 31, 2004 in exchange for convertible bonds. Section 5 (1) and (2) sentence 2 of the Articles of Association are amended accordingly. EUR 60,235,358.30. After the conversion of the convertible bonds into new inh.shares, the contingent capital 2000 still amounts to EUR 2,528,641.70. As not registered, the new shares are issued at the amount of the accounting value of the share in the share capital. The share capital is now divided into 46.334891 no-par value shares.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: UCB Pharma GmbH, Monheim a. Rhein, Germany.